- Home
- AUDC vs SGHT Comparison
AUDC vs SGHT Comparison
Compare AUDC & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUDC
- SGHT
- Stock Information
- Founded
- AUDC 1992
- SGHT 2011
- Country
- AUDC Israel
- SGHT United States
- Employees
- AUDC N/A
- SGHT N/A
- Industry
- AUDC Telecommunications Equipment
- SGHT Medical Specialities
- Sector
- AUDC Utilities
- SGHT Health Care
- Exchange
- AUDC Nasdaq
- SGHT Nasdaq
- Market Cap
- AUDC 289.7M
- SGHT 304.4M
- IPO Year
- AUDC 1999
- SGHT 2021
- Fundamental
- Price
- AUDC $11.07
- SGHT $2.86
- Analyst Decision
- AUDC Buy
- SGHT Buy
- Analyst Count
- AUDC 2
- SGHT 7
- Target Price
- AUDC $10.00
- SGHT $5.02
- AVG Volume (30 Days)
- AUDC 89.1K
- SGHT 234.3K
- Earning Date
- AUDC 02-04-2025
- SGHT 03-06-2025
- Dividend Yield
- AUDC 4.98%
- SGHT N/A
- EPS Growth
- AUDC 78.82
- SGHT N/A
- EPS
- AUDC 0.40
- SGHT N/A
- Revenue
- AUDC $244,181,000.00
- SGHT $79,543,000.00
- Revenue This Year
- AUDC $4.99
- SGHT $1.74
- Revenue Next Year
- AUDC $6.64
- SGHT $4.81
- P/E Ratio
- AUDC $25.20
- SGHT N/A
- Revenue Growth
- AUDC N/A
- SGHT N/A
- 52 Week Low
- AUDC $7.70
- SGHT $2.68
- 52 Week High
- AUDC $14.45
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- AUDC 64.69
- SGHT 37.78
- Support Level
- AUDC $9.92
- SGHT $2.69
- Resistance Level
- AUDC $10.34
- SGHT $3.15
- Average True Range (ATR)
- AUDC 0.32
- SGHT 0.18
- MACD
- AUDC -0.02
- SGHT 0.01
- Stochastic Oscillator
- AUDC 87.98
- SGHT 37.00
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.